Why focus on Lp(a)?
10' education - Sep. 13, 2021 - Prof. Naveed Sattar, MD, PhD - Glasgow, UK - Online CME
Click here to watch this as part of CME accredited course
Video navigation menu
Overview on lipoproteins 0:21
What is Lp(a)? 2:04
Lp(a) and CVD 4:55
Lp(a) reduction 6:50
Do you measure Lp(a) in all your patients?
- Yes, at least once in all adult patients
- No, only in those with high LDL-c levels
- No, because there is no therapy
Educational information
This lecture by prof. Naveed Sattar was part of an accredited symposium "Lp(a): from CV risk marker to therapeutic target" held during the virtual ESC Congress 2021.
Faculty
Naveed Sattar, MD, PhD is Professor of Metabolic Medicine, University of Glasgow. He is an academic (active clinically) experienced in biomarker studies/trials investigating the causes, prevention and management of diabetes, obesity and heart disease.
Disclosures
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding
Funding for this educational program was provided by unrestricted educational grants received from Sanofi and Novartis.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: